Scholarlink

<p>To describe a revised surgical approach for robotic-assisted laparoscopic radical prostatectomy and evaluate its safety, functional outcomes, urinary symptoms, quality of life, and short-term oncological results.&#xa0;A total of 61 patients at a large university hospital underwent modified maximum peri-prostatic anatomy preserving-robotic assisted laparoscopic radical prostatectomy (MPAP-RALP) from June 2019 to June 2022.&#xa0;The median surgery time and blood loss were 257.0&#xa0;min and 200.0 mL. Three patients had Clavien–Dindo grade II complications, and only one patient had Clavien–Dindo grade III complications. No patients died. 12 (19.7%) patients with surgical margins. 13 (21.3%) and 9 (14.8%) patients had evidence of PSA persistence after 1 month and 6–8 postoperative weeks. Continence rates continued to improve at 1 month (95.1%), 3 months (95.1%), 6 months (96.7%), and 12 months after surgery. No patients had serious urinary symptoms, and 2 (3.3%) patients were dissatisfied after 1 month surgery about quality of life.&#xa0;In conclusion, the modified MPAP-RALP is feasible and can be performed safely by an experienced urologic surgeon. Preliminary evidence suggests that the modified MPAP-RALP facilitates early continence recovery, does not affect surgical margin rates, reduces surgical complications, and enhances quality of life.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Safety and functional outcomes of modified maximum peri-prostatic anatomy preserving-robotic assisted laparoscopic radical prostatectomy base on Da Vinci robot

  • 期刊论文

  • 发表日期：

    2025年12月16日

查看全文
  • Chao-Yu Liao,
  • Min Deng,
  • Liang Liu,
  • Wen-Hao Xu,
  • Ze-Yu Huang,
  • Zhi-Wen Chen,
  • Yi-Lun Yi,
  • Qing-Jian Wu,
  • Jing-Zhen Zhu,
  • Yu Chen,
  • Ji Zheng

摘要

To describe a revised surgical approach for robotic-assisted laparoscopic radical prostatectomy and evaluate its safety, functional outcomes, urinary symptoms, quality of life, and short-term oncological results. A total of 61 patients at a large university hospital underwent modified maximum peri-prostatic anatomy preserving-robotic assisted laparoscopic radical prostatectomy (MPAP-RALP) from June 2019 to June 2022. The median surgery time and blood loss were 257.0 min and 200.0 mL. Three patients had Clavien–Dindo grade II complications, and only one patient had Clavien–Dindo grade III complications. No patients died. 12 (19.7%) patients with surgical margins. 13 (21.3%) and 9 (14.8%) patients had evidence of PSA persistence after 1 month and 6–8 postoperative weeks. Continence rates continued to improve at 1 month (95.1%), 3 months (95.1%), 6 months (96.7%), and 12 months after surgery. No patients had serious urinary symptoms, and 2 (3.3%) patients were dissatisfied after 1 month surgery about quality of life. In conclusion, the modified MPAP-RALP is feasible and can be performed safely by an experienced urologic surgeon. Preliminary evidence suggests that the modified MPAP-RALP facilitates early continence recovery, does not affect surgical margin rates, reduces surgical complications, and enhances quality of life.